TVGN
What one share of Tevogen holds
Biological Products, (No Diagnostic Substances)
Tevogen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$6.32 |
|---|---|
| Cash and investments | $0.25 |
| Book value | −$2.09 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$122.17 | $0.27 | −$16.77 | — | — |
| 2024 | — | −$3.50 | — | −$4.09 | — | −$1.87 |
| 2025 | — | −$8.08 | $0.02 | −$3.73 | — | −$2.05 |